Healthcare -
Biotechnology - NASDAQ - US
$ 23.46
-0.509 %
$ 3.38 B
Market Cap
-8.5
P/E
DNLI - TOTAL EQUITY
Total Equity DNLI - Denali Therapeutics Inc.
1.03 B
LAST VALUE
3.51%
2 YEAR CAGR
13.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR